DeepMed I/O Quality Policy

Our mission at DeepMed I/O , is to use AI to increase the accuracy and speed of diagnostic processes and deliver personalized care solutions for patients, thus prolonging their survival and improving their quality of life.

DeepMed I/O is committed to design, develop and produce safe and effective products to applicable specifications that meet national and International Standards and Regulatory Requirements.

To meet customers satisfaction without contradicting Standard and Regulatory Requirements.

To meet the highest standards of compliance for our business.

To monitor and track the performance of our Quality Management System via key performance indicators.

To continuously improve the Quality Management System.

The Company’s top management considers itself a leader that is involved in all aspects of this policy’s implementation, and through its Quality Representative is solely responsible for the quality of its product, utilizing personal commitment of all its employees.

DeepMed I/O provides the appropriate human and financial resources as well as the necessary equipment to carry out the design, development, production, technical support, the distribution of the product(s) and finally to achieve its objectives.

DeepMed I/O has developed a Quality Management System to be compliant to ISO 13485:2016 as well as the Council Directive MDD 93/42/EEC for Medical Devices, article 9 of IVDD 98/79 and ISO 62304:2006 + A1:2015.

DeepMed I/O has developed a Quality System which adheres to the major principles of Good Manufacturing Practice (GMP) and the Good Distribution Practice (GDP) for Medical Devices and selected excerpts from the EU GDP for Medicinal Products in its daily function and procedures.

DeepMed I/O developed and implemented a quality management system to demonstrate its ability to consistently provide product that meets customer and regulatory requirements, and to address customer satisfaction through the effective application of the system, including continual improvement and the prevention of nonconformity.

Managing Director
Konstantinos Vougas

Athens, 6/05/2020